Rituximab alone proves effective in the treatment of refractory, severe stage III AIDS-related non-Hodgkin's paediatric lymphoma

AIDS. 2003 Sep 26;17(14):2146-8. doi: 10.1097/00002030-200309260-00027.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Adolescent
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • Female
  • Humans
  • Lymphoma, Follicular / etiology*
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab